These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25205218)

  • 1. Soy β-conglycinin retards progression of diabetic nephropathy via modulating the insulin sensitivity and angiotensin-converting enzyme activity in rats fed with high salt diet.
    Yeh WJ; Yang HY; Chen JR
    Food Funct; 2014 Nov; 5(11):2898-904. PubMed ID: 25205218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of β-conglycinin on renal function and nephrin expression in early streptozotocin-induced diabetic nephropathy rats.
    Yang HY; Wu LY; Yeh WJ; Chen JR
    Br J Nutr; 2014 Jan; 111(1):78-85. PubMed ID: 23803175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary β-Conglycinin Modulates Insulin Sensitivity, Body Fat Mass, and Lipid Metabolism in Obese Otsuka Long-Evans Tokushima Fatty (OLETF) Rats.
    Kawabeta K; Hase-Tamaru S; Yuasa M; Suruga K; Sugano M; Koba K
    J Oleo Sci; 2019 Apr; 68(4):339-350. PubMed ID: 30867392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
    Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
    Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-conglycinin lowers very-low-density lipoprotein-triglyceride levels by increasing adiponectin and insulin sensitivity in rats.
    Tachibana N; Iwaoka Y; Hirotsuka M; Horio F; Kohno M
    Biosci Biotechnol Biochem; 2010; 74(6):1250-5. PubMed ID: 20530915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein.
    Yamazaki T; Kishimoto K; Miura S; Ezaki O
    J Nutr Biochem; 2012 Feb; 23(2):123-32. PubMed ID: 21447441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption.
    Moriyama T; Kishimoto K; Nagai K; Urade R; Ogawa T; Utsumi S; Maruyama N; Maebuchi M
    Biosci Biotechnol Biochem; 2004 Feb; 68(2):352-9. PubMed ID: 14981298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soya protein β-conglycinin ameliorates fatty liver and obesity in diet-induced obese mice through the down-regulation of PPARγ.
    Li D; Ikaga R; Yamazaki T
    Br J Nutr; 2018 Jun; 119(11):1220-1232. PubMed ID: 29770757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of soy protein hydrolysate on blood pressure and angiotensin-converting enzyme activity in rats with chronic renal failure.
    Yang HY; Chen JR; Chang LS
    Hypertens Res; 2008 May; 31(5):957-63. PubMed ID: 18712051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-conglycinin embeds active peptides that inhibit lipid accumulation in 3T3-L1 adipocytes in vitro.
    Martinez-Villaluenga C; Bringe NA; Berhow MA; Gonzalez de Mejia E
    J Agric Food Chem; 2008 Nov; 56(22):10533-43. PubMed ID: 18947234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of soybean beta-conglycinin on hepatic lipid metabolism and fecal lipid excretion in normal adult rats.
    Fukui K; Kojima M; Tachibana N; Kohno M; Takamatsu K; Hirotsuka M; Kito M
    Biosci Biotechnol Biochem; 2004 May; 68(5):1153-5. PubMed ID: 15170126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single ingestion of soy β-conglycinin induces increased postprandial circulating FGF21 levels exerting beneficial health effects.
    Hashidume T; Kato A; Tanaka T; Miyoshi S; Itoh N; Nakata R; Inoue H; Oikawa A; Nakai Y; Shimizu M; Inoue J; Sato R
    Sci Rep; 2016 Jun; 6():28183. PubMed ID: 27312476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soybean β-conglycinin improves carbohydrate and lipid metabolism in Wistar rats.
    Inoue N; Fujiwara Y; Kato M; Funayama A; Ogawa N; Tachibana N; Kohno M; Ikeda I
    Biosci Biotechnol Biochem; 2015; 79(9):1528-34. PubMed ID: 25913002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipid-improving effect of soyabean β-conglycinin in hyperlipidaemic menopausal women.
    Ma D; Taku K; Zhang Y; Jia M; Wang Y; Wang P
    Br J Nutr; 2013 Nov; 110(9):1680-4. PubMed ID: 23561330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy β-Conglycinin Peptide Attenuates Obesity and Lipid Abnormalities in Obese Model OLETF Rats.
    Wanezaki S; Saito S; Inoue N; Tachibana N; Shirouchi B; Sato M; Yanagita T; Nagao K
    J Oleo Sci; 2020; 69(5):495-502. PubMed ID: 32378551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction by phytate-reduced soybean beta-conglycinin of plasma triglyceride level of young and adult rats.
    Aoyama T; Kohno M; Saito T; Fukui K; Takamatsu K; Yamamoto T; Hashimoto Y; Hirotsuka M; Kito M
    Biosci Biotechnol Biochem; 2001 May; 65(5):1071-5. PubMed ID: 11440119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein hydrolysates from beta-conglycinin enriched soybean genotypes inhibit lipid accumulation and inflammation in vitro.
    Martinez-Villaluenga C; Dia VP; Berhow M; Bringe NA; Gonzalez de Mejia E
    Mol Nutr Food Res; 2009 Aug; 53(8):1007-18. PubMed ID: 19603404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease.
    Wanezaki S; Tachibana N; Nagata M; Saito S; Nagao K; Yanagita T; Kohno M
    Obes Res Clin Pract; 2015; 9(2):168-74. PubMed ID: 25890430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The α' subunit of β-conglycinin and various glycinin subunits of soy are not required to modulate hepatic lipid metabolism in rats.
    Chatterjee C; Liu J; Wood C; Gagnon C; Cober ER; Frégeau-Reid JA; Gleddie S; Xiao CW
    Eur J Nutr; 2018 Apr; 57(3):1157-1168. PubMed ID: 28324208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.